BrainRepair UG: Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns
(Bochum, Germany): One of the most successful inventors and entrepreneurs who masterminded the unprecedented success of Qiagen N.V. from a start-up to a 10 billion market cap enterprise has taken the decision to refocus his activities on BrainRepair UG, a spin-off of the Ruhr-University Bochum (RUB). BrainRepair UG has developed a unique method based on own (autologous) cord blood stem cells to treat brain damage and cerebral palsy (CP) in newborns affecting 70,000 babies in the EU each year. Metin Colpan’s patented invention has become a standard method recommended by the World Health Organization (WHO) and is used by researchers all over the world, changing the way they can access, purify and understand genetic data in DNA and RNA. The European Patent Office states “…The tireless work of German scientist Metin Colpan over four decades has paved the way for rapid and effective genetic data analysis, enabling researchers to better detect disease and unlocking new therapies for conditions, including COVID-19,” and Prof. Dr. Arne Jensen, Co-Founder and CEO of BrainRepair UG, continues “We are delighted that we now can draw on the vast experience Dr. Colpan is offering us as Member of the Board of Directors and Chairman of the Advisory Board on our way to the stock market at Nasdaq First North for which the IPO is planned in November 2021.” BrainRepair UG’s stem cell product has been granted the worldwide first ‘Orphan Drug Designation’ (ODD) by the European Commission and the European Medicines Agency. This designation guarantees market exclusivity in all EU member states for 12 years upon market authorisation. Prof. Arne Jensen stresses, “All our personal, scientific, clinical, and philanthropic efforts serve the ultimate goal – to combat infantile Cerebral palsy, the most common disability in childhood, and stop CP in children!”
About Qiagen N.V.
QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries.[16] QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer. The main operative headquarters are located in Hilden, Germany. Number of employees: about 5,000. Total equity: US $2,634.970 million. Industry: Biotechnology. Total assets: US $5,748.332 million. Market capitalization: US $ 11,123 billion.
About BrainRepair UG
BrainRepair UG is a clinical stage start-up developing cutting edge stem cell treatments based on human cord blood for a wide range of indications related to brain injury in children including those caused by oxygen lack and inflammation (PVL, HIE, NE), hemorrhage, stroke, cerebral palsy (CP), traumatic brain injury (TBI), and spinal cord injury (SCI). BrainRepair UG is the first Biotech company worldwide whose stem cell products have been awarded ‘Orphan Medicinal Product Designations’ for the treatment of brain injury in newborn infants (PVL, NE) by the European Commission and the European Medicines Agency, EMA. BrainRepair’s Headquarter is in Bochum, Germany. You may visit the website at https://brainrepair.eu/ for more information.
Links:
Metin Colpan (DE) - Finalist for the European Inventor Award 2021 – EPO https://www.epo.org/news-events/events/european-inventor/finalists/2021/colpan.html
Autologous Cord Blood Therapy for Infantile Cerebral Palsy: From Bench to Bedside,Obstet Gynecol Int vol.2014,12p; https://www.hindawi.com/journals/ogi/2014/976321/
First Autologous Cord Blood Therapy for Pediatric Ischemic Stroke and Cerebral Palsy Caused by Cephalic Molding during Birth: Individual Treatment with Mononuclear Cells", Case Reports in Transplantation, vol. 2016, Article ID 1717426, 9 pages, 2016. https://www.hindawi.com/journals/crit/2016/1717426/
EMA Orphan medicinal Product Designation Periventricular leukomalacia (PVL): https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3161744
EMA Orphan medicinal Product Designation Newborn encephalopathy (NE): https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3161743
Contacts
BrainRepair UG (haftungsbeschränkt)
Prof. Dr. med. Arne Jensen, MD, MBA
Ruhr-University Bochum
Campus Clinic Gynaecology
Universitätsstr. 136
44799 Bochum, Germany
Tel.: +49 234 588 196-0
Fax.: +49 234 588 196-19
Email: arne.jensen@brainrepair.eu
Images

About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Deutsche Welthungerhilfe e.V. : $1 Million Seeding The Future Global Food System Challenge Now Open for Submissions15.10.2025 08:51:18 CEST | Press release
Bonn, Germany – October 15, 2025 – Global innovators are invited to apply for the Seeding The Future Global Food System Challenge (GFSC), hosted by Welthungerhilfe (WHH) and funded by the Seeding The Future Foundation (STF). The Challenge seeks high potential, scalable ideas that can transform food systems globally to be more nutritious, sustainable, and equitable, particularly in the Global South.
Health is a Political Choice: Global Leaders Call for Shared Responsibility at the World Health Summit, Gallup and GPMB Release Landmark Reports on Emotional Wellbeing and Pandemic Preparedness14.10.2025 09:59:45 CEST | Press release
(Berlin, Germany, October 13, 2025) – Global leaders reaffirmed their commitment to health as a political priority and a cornerstone of peace and resilience on day 2 of the World Health Summit, the leading platform for global health. Against the backdrop of geopolitical crises, global leaders called for shared responsibility in shaping a healthier, more resilient world on the World Health Summit stage. Nina Warken, German Federal Health Minister, emphasized: “Germany is and remains a reliable and committed partner of the World Health Summit and also of WHO. In view of the current challenges, it is more important than ever to engage in constructive dialogue and work together to strengthen global health. The World Health Summit offers a good opportunity to deepen cooperation with international partners. Beyond that, we are also committed to consolidating international cooperation and strengthening institutions such as WHO. Germany will live up to its leadership in global health and inter
Expo 2025 Osaka draws to a close today: Koelnmesse welcomed three million visitors to the award-winning German Pavilion13.10.2025 14:52:41 CEST | Press release
After 184 days, the German Pavilion “Wa! Germany” at Expo 2025 in the Japanese city of Osaka has closed its doors. More than three million people from around the world visited the pavilion during this time, and it has now been recognised with two awards from the Bureau International des Expositions (BIE) – the Sustainability Award and the Silver Award for Theme Development. Koelnmesse GmbH, commissioned by the Germany’s Federal Ministry for Economic Affairs and Energy (BMWE) to organise and operate the German Pavilion, reports a resounding success. “The German Pavilion has demonstrated impressively how large-scale international projects made in Germany can captivate audiences worldwide,” said Gerald Böse, CEO of Koelnmesse GmbH. “The BIE’s awards are a special acknowledgement of the concept, the outstanding teamwork of all those involved – and clear proof that Koelnmesse continues to set benchmarks in international competition.” A flagship project for circular innovation Under the them
Quivo and GWC Launch Strategic Partnership for E-Commerce Fulfillment in the Gulf States13.10.2025 09:00:00 CEST | Press release
Vienna/Doha, October 13, 2025 – European technology and logistics scale-up Quivo and GWC, a MENA logistics leader, are joining forces to meet the growing demand for professional e-commerce fulfillment in the Gulf States. The partnership, sealed through a strategic investment of EUR 5.2 million by GWC, marks the beginning of a joint expansion into the markets of Qatar, the United Arab Emirates (UAE), and Saudi Arabia.
Germans would value more trustworthy online health information10.10.2025 12:00:23 CEST | Press release
Most people these days look online for answers to questions on health. However, many have doubts on the integrity and quality of the information provided by social media platforms and AI chatbots. The Bertelsmann Stiftung would like to contribute to promoting reliable sources and increasing confidence in digital information on health by means of its new "InfoCure" international initiative.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom